Suzhou Sepax Technologies(688758)
Search documents
赛分科技(688758) - 2025 Q3 - 季度财报
2025-10-27 08:10
Financial Performance - The company's operating revenue for Q3 2025 reached ¥119,788,506.40, representing an increase of 81.39% compared to the same period last year[3] - Total profit for the quarter was ¥45,199,489.74, a significant increase of 144.48% year-over-year[3] - Net profit attributable to shareholders was ¥39,552,647.11, reflecting a growth of 141.05% compared to the previous year[3] - The basic earnings per share for the quarter was ¥0.0950, up 112.12% from the same period last year[4] - The company reported a total profit for the year-to-date of ¥108,079,853.83, which is a 66.04% increase compared to the same period last year[3] - Total operating revenue for the first three quarters of 2025 reached ¥302,421,404.15, a significant increase of 38.3% compared to ¥218,532,533.42 in the same period of 2024[17] - Net profit for the first three quarters of 2025 was ¥93,645,705.20, up 68.5% from ¥55,561,721.27 in the first three quarters of 2024[18] - Operating profit increased to ¥108,154,429.72, representing a growth of 65.5% compared to ¥65,356,259.75 in the previous year[18] - The total comprehensive income for the first three quarters of 2025 was ¥91,960,348.22, compared to ¥54,042,954.92 in the same period of 2024, reflecting a growth of 70.3%[19] - Basic earnings per share for the first three quarters of 2025 were ¥0.2268, up from ¥0.1487 in the previous year, marking a 52.5% increase[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,427,105,125.21, an increase of 20.70% from the end of the previous year[4] - As of September 30, 2025, the total assets of Suzhou Saifen Technology Co., Ltd. amounted to ¥1,427,105,125.21, an increase from ¥1,182,310,293.37 as of December 31, 2024, reflecting a growth of approximately 20.7%[12] - The company's current assets reached ¥858,561,819.92, compared to ¥590,390,238.19 in the previous year, indicating a year-over-year increase of about 45.4%[12] - Total liabilities increased to ¥96,998,335.76, up from ¥84,269,862.24, reflecting a growth of 15%[14] - The company's total equity attributable to shareholders reached ¥1,319,690,139.06, a rise of 21.2% from ¥1,088,064,865.48 year-over-year[14] - The total liabilities of the company are not explicitly stated, but the increase in current liabilities, particularly accounts payable, which decreased from ¥13,091,433.61 to ¥7,108,618.89, indicates a strategic management of payables[12] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥45,456,049.79, down 16.34% compared to the previous year[3] - Cash inflow from operating activities was ¥274,608,565.13, compared to ¥241,262,774.62 in the same period last year, indicating a growth of 13.8%[22] - The net cash flow from operating activities was $45,456,049.79, a decrease of 16.5% compared to $54,336,238.00 in the previous period[23] - Cash outflow from operating activities totaled $229,152,515.34, an increase of 22.4% from $186,926,536.62[23] - Cash inflow from investment activities totaled $144,242,198.75, down 34.6% from $220,728,330.02 in the prior period[23] - The net cash flow from investment activities was -$136,696,544.55, worsening from -$121,957,503.69 year-over-year[23] - Total cash inflow from financing activities was $210,595,309.31, significantly higher than $3,212,779.50 in the previous period[23] - The net cash flow from financing activities improved to $157,771,514.06 from -$6,886,002.91 in the prior period[23] - The ending cash and cash equivalents balance increased to $167,895,271.06, compared to $92,106,811.04 at the end of the previous period[23] Research and Development - Research and development expenses totaled ¥16,699,960.62 for the quarter, accounting for 13.94% of operating revenue, a decrease of 3.89 percentage points year-over-year[4] - Research and development expenses rose to ¥40,600,253.46, an increase of 20.3% from ¥33,730,244.06 in the same period last year[17] - The company has focused on enhancing product performance and core technology through independent research and development, driving growth in both new and existing customer projects[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,159[9] - The company has not reported any significant changes in shareholder structure or related party transactions during the reporting period[11] Product and Technology - There are no new product launches or technological advancements mentioned in the conference call, focusing instead on financial performance and asset management strategies[11]
赛分科技10月16日获融资买入2407.10万元,融资余额5482.35万元
Xin Lang Cai Jing· 2025-10-17 01:41
Core Insights - On October 16, 2023, Saifen Technology's stock rose by 9.02%, with a trading volume of 255 million yuan [1] - The company recorded a net financing purchase of 11.97 million yuan on the same day, with a total financing balance of 54.82 million yuan, representing 6.93% of its market capitalization [1][2] Financial Performance - For the period from January to June 2025, Saifen Technology achieved a revenue of 183 million yuan, reflecting a year-on-year growth of 19.76% [2] - The net profit attributable to the parent company for the same period was 53.66 million yuan, marking a year-on-year increase of 40.91% [2] Shareholder Information - As of June 30, 2025, the number of shareholders in Saifen Technology was 10,500, a decrease of 4.63% from the previous period [2] - The average number of circulating shares per shareholder increased by 4.86% to 3,779 shares [2] - The company has distributed a total of 27.90 million yuan in dividends since its A-share listing [3] Institutional Holdings - As of June 30, 2025, the largest circulating shareholder was Southern Science and Technology Innovation Board 3-Year Open Mixed Fund, holding 791,100 shares, a decrease of 893,600 shares from the previous period [3] - Galaxy Medical Mixed A Fund has exited the list of the top ten circulating shareholders [3]
赛分科技龙虎榜:营业部净买入1664.14万元
Zheng Quan Shi Bao Wang· 2025-10-16 12:44
Core Viewpoint - On October 16, 2023, Saifen Technology (688758) closed at 18.62 yuan, marking a 9.02% increase with a trading volume of 2.55 billion yuan and a turnover rate of 31.31% [2][3] Trading Activity - The stock was the only one listed on the daily trading leaderboard due to its turnover rate exceeding 30% [2] - The top five trading departments accounted for a total transaction amount of 73.50 million yuan, with a net buying amount of 16.64 million yuan [2] - The largest buying department was Guotai Junan Securities Headquarters, with a purchase amount of 12.79 million yuan, followed by Guotai Junan Securities Chengdu Longteng East Road with 10.17 million yuan [3] Fund Flow - The stock experienced a net inflow of 12.68 million yuan from main funds throughout the day [3] - The top buying departments included: - Guotai Junan Securities Headquarters: 12.79 million yuan - Guotai Junan Securities Chengdu Longteng East Road: 10.17 million yuan - Goldman Sachs (China) Securities Shanghai Pudong New Area: 8.82 million yuan [3] - The top selling department was Dongwu Securities Suzhou Xiangcheng Cailian Road with a selling amount of 8.96 million yuan [3]
化学制药板块10月16日涨0.45%,向日葵领涨,主力资金净流出1822.69万元
Zheng Xing Xing Ye Ri Bao· 2025-10-16 08:20
Core Insights - The chemical pharmaceutical sector experienced a slight increase of 0.45% on October 16, with Sunflower leading the gains [1] - The Shanghai Composite Index closed at 3916.23, up 0.1%, while the Shenzhen Component Index closed at 13086.41, down 0.25% [1] Stock Performance - Sunflower (300111) saw a closing price of 9.00, with a significant increase of 10.97% and a trading volume of 4.1856 million shares, amounting to a transaction value of 36.12 billion [1] - Duorui Pharmaceutical (301075) closed at 50.80, up 10.63%, with a trading volume of 74,600 shares and a transaction value of 3.72 billion [1] - Asia-Pacific Pharmaceutical (002370) closed at 7.55, up 10.06%, with a trading volume of 185,700 shares and a transaction value of 1.40 billion [1] - Other notable gainers include Luoxin Pharmaceutical (002793) with a 9.94% increase and a closing price of 5.53, and Saifen Technology (688758) with a 9.02% increase and a closing price of 18.62 [1] Fund Flow Analysis - The chemical pharmaceutical sector experienced a net outflow of 18.2269 million from institutional investors, while retail investors saw a net outflow of 83.7 billion [2] - Conversely, speculative funds recorded a net inflow of 855 million [2] Individual Stock Fund Flow - Shutaishen (300204) had a net inflow of 123 million from institutional investors, while retail investors experienced a net outflow of 22.4 million [3] - Baijishenzhou (688235) saw a net inflow of 123 million from institutional investors but a net outflow of 118 million from speculative funds [3] - Xingqi Eye Medicine (300573) recorded a net inflow of 87.1576 million from institutional investors, with retail investors facing a net outflow of 73.7128 million [3]
今日282只个股突破五日均线
Zheng Quan Shi Bao Wang· 2025-10-16 07:46
Core Points - The Shanghai Composite Index closed at 3916.23 points, above the five-day moving average, with a slight increase of 0.10% [1] - The total trading volume of A-shares reached 1,948.66 billion yuan [1] - A total of 282 A-shares have surpassed the five-day moving average, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - The stocks with the highest deviation rates from the five-day moving average include: - Xiangnong Chip (300475) with a deviation rate of 9.93% and a daily increase of 16.70% [1] - Yingjixin (688209) with a deviation rate of 8.92% and a daily increase of 14.24% [1] - Luchang Technology (002813) with a deviation rate of 8.00% and a daily increase of 9.98% [1] Trading Activity - The trading turnover rates for the top stocks with significant price movements include: - Xiangnong Chip at 15.82% [1] - Yingjixin at 12.53% [1] - Luchang Technology at 4.44% [1] Additional Notable Stocks - Other stocks that recently crossed the five-day moving average with smaller deviation rates include: - Yuyue Medical (乖离率较小) [1] - Donggang Shares (乖离率较小) [1] - Fangzheng Electric (乖离率较小) [1]
268只股短线走稳 站上五日均线
Zheng Quan Shi Bao Wang· 2025-10-16 06:31
Core Points - The Shanghai Composite Index is at 3910.12 points, slightly down by 0.05%, and above the five-day moving average [1] - The total trading volume of A-shares today is 15,714.28 billion yuan, with 268 A-shares breaking through the five-day moving average [1] Summary by Category Stock Performance - Notable stocks with significant deviation from the five-day moving average include: - Yingjixin (688209) with a deviation rate of 10.48% and a daily increase of 16.34% [1] - Shannon Chip (300475) with a deviation rate of 10.38% and a daily increase of 17.30% [1] - Wanma Technology (300698) with a deviation rate of 8.70% and a daily increase of 12.09% [1] - Other stocks with smaller deviation rates include: - Meidixi, Ruifeng New Materials, and Tongrentang, which have just crossed the five-day moving average [1] Trading Data - The trading data for stocks that broke through the five-day moving average includes: - Yingjixin: Latest price 24.42 yuan, five-day moving average 22.10 yuan, turnover rate 10.83% [1] - Shannon Chip: Latest price 105.22 yuan, five-day moving average 95.33 yuan, turnover rate 14.24% [1] - Wanma Technology: Latest price 50.61 yuan, five-day moving average 46.56 yuan, turnover rate 16.94% [1]
格隆汇公告精选︱硕贝德:预计前三季度净利润同比增长1258.39%—1313.24%;三花智控:获得机器人大额订单的传言不属实





Ge Long Hui· 2025-10-15 15:30
Group 1: Company Announcements - Sanhua Intelligent Control denied rumors of receiving a large robot order [1] - Shengfang Textile A's subsidiary plans to invest in a 1.49-meter wide polarizer production line project [1] - Rongji Software's subsidiary signed a contract worth 126 million yuan for the construction of Henan Rongji Software Park [1] - Nar Holdings intends to acquire at least 51% of Shanghai Feilai Testing [1] - Hengmingda plans to repurchase shares worth 200 million to 400 million yuan [1] - Shuo Beid's net profit for the first three quarters is expected to increase by 1258.39% to 1313.24% year-on-year [1] - Huizhiwei's major fund plans to reduce holdings by no more than 4.6684 million shares [1] - Junpu Intelligent plans to raise no more than 1.161 billion yuan through a private placement [1] - Sifang Optoelectronics received a project notification from a client, with a total contract amount expected to be 59 million yuan [1] Group 2: Performance Forecasts - Saifen Technology expects a net profit increase of 65% to 80% year-on-year for the first three quarters [2] - Asia-Pacific Co. anticipates a net profit increase of 97.38% to 113.30% year-on-year for the first three quarters [2] Group 3: Shareholding Changes - Xin Hongze's controlling shareholder plans to reduce holdings by no more than 3% [2] - Ugreen Technology's management and its concerted actions plan to reduce holdings by no more than 1.5% [2] - Sanfeng Intelligent's director and his concerted actions plan to reduce holdings by no more than 2.85% [2] - Huizhiwei's major fund plans to reduce holdings by no more than 4.6684 million shares [2] Group 4: Other Fundraising Activities - Digital Zhengtong plans to raise no more than 1.05 billion yuan through a private placement [2] - Deli Co. plans to raise no more than 720 million yuan through a private placement [2] - Junpu Intelligent plans to raise no more than 1.161 billion yuan through a private placement [2] - Sifang Optoelectronics received a project notification from a client, with a total contract amount expected to be 59 million yuan [2]
公告精选︱硕贝德:预计前三季度净利润同比增长1258.39%—1313.24%;三花智控:获得机器人大额订单的传言不属实
Sou Hu Cai Jing· 2025-10-15 14:43
Group 1 - Sanhua Intelligent Control (002050.SZ) denied rumors of receiving a large robot order [1] - Deep Textile A (000045.SZ) subsidiary plans to invest in a 1.49-meter wide polarizer production line project [1] - Rongji Software (002474.SZ) subsidiary signed a 126 million yuan contract for the construction of Henan Rongji Software Park [1] Group 2 - Nar Holdings (002825.SZ) intends to acquire at least 51% equity in Shanghai Feilai Testing [1] - Hengmingda (002947.SZ) plans to repurchase shares worth 200 million to 400 million yuan [1] - Suobede (300322.SZ) expects a net profit growth of 1258.39% to 1313.24% year-on-year for the first three quarters [1] Group 3 - New Hongze (002836.SZ) major shareholder plans to reduce holdings by no more than 3% [1] - Ugreen Technology (301606.SZ) management and its concerted parties plan to reduce holdings by no more than 1.5% [1] - Wisdom Micro (688512.SZ) major fund plans to reduce holdings by no more than 466,840 shares [1] Group 4 - Digital Zhengtong (300075.SZ) plans to raise no more than 1.05 billion yuan through a private placement [2] - Delixi Shares (002571.SZ) plans to raise no more than 720 million yuan through a private placement [2] - Junpu Intelligent (688306.SZ) plans to raise no more than 1.161 billion yuan through a private placement [2] - Sifang Optoelectronics (688665.SZ) received a project notification from a client, with a total contract amount expected to be 59 million yuan [2]
赛分科技:2025年前三季度业绩预告的自愿性披露公告
Zheng Quan Ri Bao Zhi Sheng· 2025-10-15 13:12
证券日报网讯 10月15日晚间,赛分科技发布公告称,经苏州赛分科技股份有限公司(以下简称"公 司")财务部门初步测算,预计公司2025年前三季度:1、实现营业收入29,500.00万元到31,700.00万 元,与上年同期相比,将增加人民币7,646.74万元到9,846.74万元,同比增长35%到45%。2、实现归 属于母公司所有者的净利润为9,000.00万元到9,800.00万元,与上年同期相比,将增加人民币3, 551.21万元到4,351.21万元,同比增长65%到80%。 (编辑 楚丽君) ...
赛分科技前三季度净利预增65%至80%
Bei Jing Shang Bao· 2025-10-15 12:12
Core Viewpoint - The company expects a significant increase in net profit for the first three quarters of 2025, projecting a profit between 90 million to 98 million yuan, representing a year-on-year growth of 65% to 80% [1] Financial Performance - The projected net profit increase is between 35.51 million to 43.51 million yuan compared to the same period last year [1] Business Strategy - The company focuses on two core areas: analytical chromatography and industrial purification, driven by technological innovation [1] - The company is leveraging the domestic substitution strategy by actively expanding new customer projects and enhancing market coverage [1] - The company is also working on converting existing customer projects into repeat purchases, thereby deepening customer cooperation [1] Operational Expansion - The dual strategy of expanding new customer projects and enhancing existing customer relationships has led to further operational scale expansion and stable profit growth [1]